While Silence Therapeutics Plc ADR has underperformed by -1.14%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SLN fell by -11.63%, with highs and lows ranging from $8.08 to $1.97, whereas the simple moving average jumped by 14.05% in the last 200 days.
On February 11, 2025, Goldman started tracking Silence Therapeutics Plc ADR (NASDAQ: SLN) recommending Sell. A report published by BMO Capital Markets on December 02, 2024, Reiterated its previous ‘Outperform’ rating for SLN. Jefferies also rated SLN shares as ‘Buy’, setting a target price of $40 on the company’s shares in an initiating report dated September 03, 2024. BMO Capital Markets Initiated an Outperform rating on January 31, 2024, and assigned a price target of $67.
Analysis of Silence Therapeutics Plc ADR (SLN)
Further, the quarter-over-quarter decrease in sales is -79.05%, showing a negative trend in the upcoming months.
To gain a thorough understanding of Silence Therapeutics Plc ADR’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. Taking into account the quick ratio of the company, currently set at 7.69, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and SLN is recording an average volume of 242.06K. On a monthly basis, the volatility of the stock is set at 7.46%, whereas on a weekly basis, it is put at 5.84%, with a loss of -3.03% over the past seven days. Furthermore, long-term investors anticipate a median target price of $33.80, showing growth from the present price of $6.08, which can serve as yet another indication of whether SLN is worth investing in or should be passed over.
How Do You Analyze Silence Therapeutics Plc ADR Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 20.01%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 21.83% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
